Xanomeline-trospium (Cobenfy™) for Schizophrenia: A Review of the Literature.Published in:Clinical Psychopharmacology & Neuroscience, 2025, v. 23, n. 1, p. 2, doi. 10.9758/cpn.24.1253By:Smith, Colin M.;Augustine, Morgan Santalucia;Dorrough, Jessica;Szabo, Steven T.;Shadaram, Särä;Hoffman, Elizabeth O. G.;Muzyk, AndrewPublication type:Article